Veterinary Medicines

Equizol 400 mg gastro-resistant granules for horses

Authorised
  • Omeprazole
Download as PDF

Product identification

Medicine name:
Equizol 400 mg gastro-resistant granules for horses
Hippozol vet. 400 mg enterogranulat til hest
Active substance:
  • Omeprazole
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Omeprazole
    80.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Gastro-resistant granules
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        2
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BC01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:
  • (ID7) 1000 gram(s): unspecified outer container with 200 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)
  • (ID6) 560 gram(s): unspecified outer container with 112 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)
  • (ID5) 500 gram(s): unspecified outer container with 100 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)
  • (ID4) 420 gram(s): unspecified outer container with 84 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)
  • (ID3) 280 gram(s): unspecified outer container with 56 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)
  • (ID2) 140 gram(s): unspecified outer container with 28 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)
  • (ID1) 70 gram(s): unspecified outer container with 14 Bag (PolyEthylene; Aluminium; Paper) each with 5 gram(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 16-11276
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0318/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 15/02/2022
Download
Norwegian (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."